Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maltitol SCHEMBL8597295 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL8094264 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Lactitol SCHEMBL9315052 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL4459148 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL15242038 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL15214336 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL21947405 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL21947406 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL22516409 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL8600574 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144748-A1 | POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4748877-A2 | STERICALLY HINDERED AMINE STABILIZER MIXTURES | BASF SE (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4748878-A2 | STERICALLY HINDERED AMINE STABILIZER MIXTURES | BASF SE (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260000694-A1 | METHODS AND COMPOSITIONS RELATED TO PREBIOTIC FORMULATIONS USEFUL IN PROMOTING UROGENITAL HEALTH | KIMBERLY CLARK CO (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250288624-A1 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-09-18 | — | — | US | disclosed |
| CN-120037990-A | Preparation method and application of amphiphilic metal base composite catalyst for monoglyceride synthesis | 常州大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20250136760-A1 | AMINO-ACID- AND AMINO-ALCOHOL-BASED POLYAMINE COMPOUNDS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-05-01 | — | — | US | disclosed |
| US-20250131346-A1 | Optimizing Environmental Lifetime of an Object | WOODS HOLE OCEANOGRAPHIC INSTITUTION | 2025-04-24 | — | — | US | disclosed |
| CN-119488455-A | A cream-like texture hair cream with keratin and its preparation method | 广州市柏凡生物科技有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| EP-2292585-A1 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT (KANSAS CITY), LLC (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20110008277-A1 | POLYOL-BASED POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-01-13 | — | — | US | disclosed |
| US-20090281195-A1 | NOVEL COCRYSTALLIZATION | S.S.C.I., INC. (US) | 2009-11-12 | — | — | US | disclosed |
| US-7452555-B2 | Cocrystallization | S.S.C.I., INC. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20080206169-A1 | Personal care composition | PROCTER & GAMBLE COMPANY, THE | 2008-08-28 | — | — | US | disclosed |
| WO-2008063441-A2 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2008-05-29 | — | — | WO | disclosed |
| US-20070287194-A1 | Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound | S.S.C.I., INC | 2007-12-13 | — | — | US | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008277-A1 | POLYOL-BASED POLYMERS | SORD, SUCLG2, SUCLG1 | L3MBTL1 4117/4885PPARG 1680/4885PPARD 2794/4885 |
| US-20250136760-A1 | AMINO-ACID- AND AMINO-ALCOHOL-BASED POLYAMINE COMPOUNDS AND MEDICAL HYDROGELS FORMED THEREFROM | CARM1, PNMT, ADM2 | L3MBTL1 3573/4885PPARG 1550/4885PPARD 2275/4885 |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | COL2A1, COLGALT1, PLOD3 | L3MBTL1 3148/4885PPARG 295/4885PPARD 1298/4885 |
| US-20260000694-A1 | METHODS AND COMPOSITIONS RELATED TO PREBIOTIC FORMULATIONS USEFUL IN PROMOTING UROGENITAL HEALTH | SI, KLK1, HKDC1 | L3MBTL1 2754/4885PPARG 4154/4885PPARD 1234/4885 |
| US-20260144748-A1 | POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME | CD44, PAM, PLOD3 | L3MBTL1 2605/4885PPARG 901/4885PPARD 2933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.